This suggest that higher levels of both NR1 and NR2B NMDA subunits and increased NMDAR sensitivity to glutamate in females may be protective and lead to differences in schizophrenia symptomology (Wickens et al., 2018). The gene discussed is GRIN2B; the disease is schizophrenia.